TKH Group N.V. (0NO1)
London Exchange · UK · prices in EUR · close of 16 Oct 2026
Key indicators
| Last close | EUR 51.88 |
|---|---|
| 52-week range | 33.72 – 55.10 |
| Return, 1 month / 3 months | −1.0% / +21.9% |
| Return, 1 year / 3 years | +43.8% / +64.2% |
| Trend | Uptrend |
| RSI (14) | 47 |
| Volatility (1 year) | 27.8% |
| Worst drawdown (1 year) | -12.6% |
| Average daily value traded | 0.21M EUR |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
TKH Group is a technology company based in the Netherlands that designs and makes systems and components for industrial and infrastructure customers. Its activities span cable and connectivity systems for telecom and building networks, machine vision and automation technology used in manufacturing, and specialised machinery for tyre production. Customers include telecom operators, construction and infrastructure firms, and industrial manufacturers who integrate these systems into their own operations and equipment.
On this site TKH Group N.V. appears as a stock on the London Exchange (UK), code 0NO1, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
TKH Group N.V. (0NO1) trades on the London Exchange in UK. It last closed at EUR 51.88 on 16 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 375 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 43.8% and over the last three months it rose 21.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.5% | ||
| From 52-week high | -5.3% | ||
| Momentum | 87 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 21.9% | ||
| 6-month return | 26.7% | ||
| 12-month return, skipping the last month | 45.2% | ||
| Risk (lower is better) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 27.8% | ||
| Worst drawdown (1 year) | -12.6% | ||
| Liquidity | 37 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.21M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.6% |
|---|---|
| 1 month | −1.0% |
| 3 months | +21.9% |
| 6 months | +26.7% |
| 1 year | +43.8% |
| 3 years | +64.2% |
| 5 years | +15.3% |
Signals
| 50-day / 200-day average | 51.53 / 43.41 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.39 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 May 2026 | EUR 1.3500 |
| 19 May 2025 | EUR 1.5000 |
| 9 May 2024 | EUR 1.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.